BRCA2 and cancer: Germline inactivating mutations in BRCA1 and/or BRCA2 cause an increased risk of early-onset breast1, 2, ovarian2, 3 and pancreatic cancer4, while somatic mutations in these two genes and BRCA1 promoter hypermethylation have also been implicated in development of these cancer types5, 6.